Nova Eye Medical (EYE) Discussion, page-140

Perhaps, but "the rumour" was never FDA approval - most of us knew that was guaranteed for a number of reasons (eg the original device was already approved)

The rumour here, I guess, is the huge sales growth that this newly approved device is expected to deliver. So not sure why people are selling before seeing if iTrack Advance can deliver this growth, especially when the share price is currently so low that it still assumes the company will have zero growth (ie even if iTrack Advance doesn't go anywhere, the share price is so low that there shouldn't be a crash or a fall if the sales continue to be stagnant)

The company is still trading at a 2x multiple to revenue, which is insanely low when you look at every company in this space, even those that aren't growing anymore!